Shopping Cart 0
Cart Subtotal
AED 0

Catheters Market by Product (Cardiovascular Catheters, Neurovascular Catheters, Urological Catheters, Intravenous Catheters, Specialty Catheters): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 19708

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 33012

Details

According to a new report published by Allied Market Research, titled, Catheters Market by Product: Global Opportunity Analysis and Industry Forecast, 2018 to 2025, the global catheters market was valued at USD 10,703 million in 2017 and is projected to reach USD 19,976 million by 2025, growing at a CAGR of 8.0% from 2018 to 2025. North America was the highest revenue contributor in 2017 and is expected to remain the same throughout the forecast period.
 
A catheter is a thin tube made from medical grade materials that serve a comprehensive range of functions. They are medical devices that can easily be inserted in the patient's body for the treatment of various diseases or even perform a surgical procedure. For instance, cardiovascular catheters are used to draw blood and provide treatments, including intravenous fluids, drugs, or blood transfusions. The scope of applications of catheters has widened, as they are used to treat various neurological, cardiovascular, urological, and other disorders, with the help of improved clinical practices and advanced technologies.
 
The catheter devices have gained significant traction in recent years owing to the significant rise in cardiovascular & urological diseases across the globe. A rise in demand for minimally invasive surgeries for the diagnosis and treatment of cardiovascular, neurological, and other diseases drives the growth of the catheters market. Further, catheter-based surgeries are minimally invasive and require shorter recovery times. Surgeries done with the help of catheters are less invasive and lead to faster recovery.
 
Based on the product, the cardiovascular segment accounted for the majority of the catheter market share of the global market in 2017. This is attributed to the significant increase in cardiovascular diseases across the globe and the surge in the use of these catheters for the treatment of the same. However, the urological catheter segment is anticipated to exhibit a prominent growth rate during the forecast period owing to the significant rise in the geriatric population and the use of these catheters to deal with inconsistency.
 
Key Findings of the Catheters market:
 
Based on the product, the cardiovascular catheters segment accounted for nearly half the share of the catheters industry in 2017.
 
The urological catheters segment is anticipated to grow at the highest growth rate throughout the forecast period.
 
Based on the region, North America accounted for a major share of the global catheters market in 2017.
 
LAMEA is anticipated to grow at the highest rate in the catheters market during the analysis period, followed by Asia-Pacific.
 
North America was the leading revenue contributor to the global market in 2017, owing to highly advanced healthcare infrastructure and new product launches by the key players. LAMEA is expected to witness the highest growth rate throughout the forecast period, owing to the increase in awareness among healthcare professionals regarding the use of catheters for the treatment and diagnosis of various diseases including urological, kidney failures, and others.
 
The report provides a comprehensive analysis of the leading companies operating in the global market such as Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, Stryker Corporation, Cook Medical, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic, Inc., Edwards Lifesciences Corp., and Vascular Solutions, Inc. The other players in the value chain (not included in the report) include Other players in the value chain include Hollister Incorporated, Manfred Sauer, Smiths Medical, Wellspect Healthcare, Cure Medical, and Convatech Inc.
READ MORE

Table Of Content

Scope

CHAPTER 1: INTRODUCTION

 

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

 

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

 

CHAPTER 2: EXECUTIVE SUMMARY

 

2.1. CXO perspective

 

CHAPTER 3: MARKET OVERVIEW

 

3.1. Market definition and scope

3.2. Key findings

 

3.2.1. Top investment pockets

3.2.2. Top Winning Strategies

 

3.3. Patent Analysis

 

3.3.1. Patent analysis by geography (2016-2018)

3.3.2. Patent analysis by applicants (2015-2016)

 

3.4. Clinical Trials For Catheters

3.5. Porters five forces analysis

3.6. Value chain analysis

 

3.6.1. Primary activities

3.6.2. Support activities

 

3.7. Market share analysis, 2017

3.8. Government regulations and reimbursements

 

3.8.1. Catheter regulation in the U.S. and Europe

3.8.2. Reimbursements

 

3.8.2.1. U.S.

 

3.8.3. Europe

 

3.9. Market dynamics

 

3.9.1. Drivers

 

3.9.1.1. Growing demand for minimally invasive procedures

3.9.1.2. Increase in adoption of catheters

3.9.1.3. Surge in geriatric population

 

3.9.2. Restraints

 

3.9.2.1.Rise in Catheter-associated Urinary Tract Infections (CAUTI)

3.9.2.2.Inadequate quality assurance

 

3.9.3. Opportunities

 

3.9.3.1. Opportunities in emerging economies

 

CHAPTER 4: CATHETERS MARKET, BY PRODUCT

 

4.1. Overview

 

4.1.1. Market size and forecast

 

4.2. Cardiovascular Catheters

 

4.2.1. Key market trends and opportunity

4.2.2. Market size and forecast

4.2.3. Electrophysiology Catheters

 

4.2.3.1. Market size and forecast

 

4.2.4. PTCA Balloons Catheters

 

4.2.4.1. Market size and forecast

 

4.2.5. Intravascular ultrasound (IVUS) Catheters

 

4.2.5.1. Market size and forecast

 

4.2.6. Percutaneous transluminal angioplasty (PTA) balloon Catheters

 

4.2.6.1. Market size and forecast

 

4.2.7. Others

 

4.2.7.1. Market size and forecast

 

4.2.7.1.1. Guiding Catheters

4.2.7.1.2. Angiography catheters

4.2.7.1.3. Pulmonary artery catheters

 

4.3. Neurovascular Catheters

 

4.3.1. Key Market Trends and Opportunity

4.3.2. Market size and forecast

 

4.4. Urological Catheters

 

4.4.1. Key Market Trends and Opportunities

4.4.2. Market size and forecast

4.4.3. Dialysis catheter

 

4.4.3.1. Market size and forecast

4.4.3.2. Hemodialysis catheter

 

4.4.3.2.1. Market size and forecast

 

4.4.3.3. Peritoneal catheter

 

4.4.3.3.1. Market size and forecast

 

4.4.4. Urinary catheter

 

4.4.4.1. Market size and forecast

4.4.4.2. Foley Catheters

 

4.4.4.2.1. Market size and forecast

 

4.4.4.3. Intermittent Catheters

 

4.4.4.3.1. Market size and forecast

 

4.4.4.4. External Catheters

 

4.4.4.4.1. Market size and forecast

 

4.5. Intravenous Catheters

 

4.5.1. Key market trends and opportunities

4.5.2. Market size and forecast

4.5.3. Central venous catheters

 

4.5.3.1. Market size and forecast

 

4.5.4. Peripheral venous catheters

 

4.5.4.1. Market size and forecast

4.5.4.2. Integrated Catheters

 

4.5.4.2.1. Market size and forecast

 

4.5.4.3. Short Catheter

 

4.5.4.3.1. Market size and forecast

 

4.6. Specialty Catheters

 

4.6.1. Key market trends and opportunity

4.6.2. Market size and forecast

4.6.3. Wound / Surgical drain

 

4.6.3.1. Market size and forecast

 

4.6.4. Oximetry

 

4.6.4.1. Market size and forecast

 

4.6.5. Thermodilution

 

4.6.5.1. Market size and forecast

 

4.6.6. IUI catheters

 

4.6.6.1. Market size and forecast

 

CHAPTER 5: CATHETERS MARKET, BY REGION

 

5.1. Overview

 

5.1.1. Market size and forecast

 

5.2. North America

 

5.2.1. Key trends and opportunities

5.2.2. North America market size & forecast, by product

5.2.3. North America market size & forecast, by country

 

5.2.3.1. U.S. market size & forecast

5.2.3.2. Canada market size & forecast

5.2.3.3. Mexico market size & forecast

 

5.3. Europe

 

5.3.1. Key trends and opportunities

5.3.2. Europe market size & forecast, by product

5.3.3. Europe market size & forecast for catheters market, by country

 

5.3.3.1. Germany market size & forecast

5.3.3.2. France market size & forecast

5.3.3.3. UK market size & forecast

5.3.3.4. Italy market size & forecast

5.3.3.5. Russia market size & forecast

5.3.3.6. Rest of Europe market size & forecast

 

5.4. Asia-Pacific

 

5.4.1. Key trends and opportunities

5.4.2. Asia-Pacific market size & forecast, by country

5.4.3. Asia-Pacific market size & forecast, by product

 

5.4.3.1. Australia market size & forecast

5.4.3.2. China market size & forecast

5.4.3.3. India market size & forecast

5.4.3.4. Japan market size & forecast

5.4.3.5. Rest of Asia-Pacific market size & forecast

 

5.5. LAMEA

 

5.5.1. Key trends and opportunities

5.5.2. LAMEA market size & forecast, by country

5.5.3. LAMEA market size & forecast, by product

 

5.5.3.1. Brazil market size & forecast

5.5.3.2. Saudi Arabia market size & forecast

5.5.3.3. Turkey market size & forecast

5.5.3.4. Rest of LAMEA market size & forecast

 

CHAPTER 6: COMPANY PROFILES

 

6.1. Abbott Laboratories

 

6.1.1. Company overview

6.1.2. Company snapshot

6.1.3. Operating business segments

6.1.4. Product portfolio

6.1.5. Business performance

6.1.6. Key strategic moves and developments

 

6.2. B. Braun Melsungen AG

 

6.2.1. Company overview

6.2.2. Company snapshot

6.2.3. Operating business segments

6.2.4. Product portfolio

6.2.5. Business performance

 

6.3. Becton, Dickinson and Company

 

6.3.1. Company overview

6.3.2. Company snapshot

6.3.3. Operating business segments

6.3.4. Product portfolio

6.3.5. Business performance

6.3.6. Key strategic moves and developments

 

6.4. Boston Scientific Corporation

 

6.4.1. Company overview

6.4.2. Company snapshot

6.4.3. Operating business segments

6.4.4. Product portfolio

6.4.5. Business performance

6.4.1. Key strategic moves and developments

 

6.5. Johnson & Johnson

 

6.5.1. Company overview

6.5.2. Company snapshot

6.5.3. Operating business segments

6.5.4. Product portfolio

6.5.5. Business performance

6.5.6. Key strategic moves and developments

 

6.6. Medtronic Plc.

 

6.6.1. Company overview

6.6.2. Company snapshot

6.6.3. Operating business segment

6.6.4. Product portfolio

6.6.5. Business performance

6.6.6. Key strategic moves and developments

 

6.7. Edwards Lifesciences Corporation

 

6.7.1. Company overview

6.7.2. Company snapshot

6.7.3. Operating business segments

6.7.4. Product portfolio

6.7.5. Business performance

 

6.8. Teleflex Incorporated

 

6.8.1. Company overview

6.8.2. Company snapshot

6.8.3. Operating business segments

6.8.4. Product portfolio

6.8.5. Business performance

 

6.9. Cook Medical Inc.

 

6.9.1. Company overview

6.9.2. Company snapshot

6.9.3. Operating business segments

6.9.4. Product portfolio

 

6.10. Stryker Corporation

 

6.10.1. Company overview

6.10.2. Company snapshot

6.10.3. Operating business segments

6.10.4. Product portfolio

6.10.5. Business performance

6.10.6. Key strategic moves and developments


List Of Figure

LIST OF FIGURES

 

FIGURE 01. CATHETERS MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*

FIGURE 06. PATENT ANALYSIS BY GEOGRAPHY (2015-2016)

FIGURE 07. PATENT ANALYSIS BY APPLICANT (2015-2016)

FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 09. LOW BARGAINING POWER OF BUYERS

FIGURE 10. LOW THREAT OF SUBSTITUTION

FIGURE 11. LOW THREAT OF NEW ENTRANTS

FIGURE 12. MODERTAE COMPETITIVE RIVALRY

FIGURE 13. VALUE CHAIN ANALYSIS

FIGURE 14. MARKET SHARE ANALYSIS, 2017

FIGURE 15. GLOBAL CATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES

FIGURE 16. U.S. CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 17. CANADA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 18. MEXICO CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 19. GERMANY CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 20. FRANCE CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 21. UK CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 22. ITALY CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 23. RUSSIA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 24. REST OF EUROPE CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 25. AUSTRALIA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 26. CHINA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 27. INDIA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 28. JAPAN CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 29. REST OF ASIA-PACIFIC CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 30. BRAZIL CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 31. SAUDI ARABIA CATHETERS MARKET, 20172025 (USD MILLION)

FIGURE 32. TURKEY CATHETERS MARKET, 20172025 (USD MILLION)

FIGURE 33. REST OF LAMEA CATHETERS MARKET, 20172025 (USD MILLION)

FIGURE 34. ABBOTT: NET SALES, 20152017 (USD MILLION)

FIGURE 35. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 36. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 37. B. BRAUN: NET SALES, 20152017(USD MILLION)

FIGURE 38. B. BRAUN: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 39. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2017(%)

FIGURE 40. BD: NET SALES, 20152017 (USD MILLION)

FIGURE 41. BD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 42. BD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 43. BOSTON SCIENTIFIC: NET SALES, 20152017 (USD MILLION)

FIGURE 44. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 45. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 46. J&J: NET SALES, 20152017 (USD MILLION)

FIGURE 47. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 48. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 49. MEDTRONIC: NET SALES, 20152017(USD MILLION)

FIGURE 50. MEDTRONIC: REVENUE SHARE PER SEGMENT 2017(%)

FIGURE 51. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY 2017(%)

FIGURE 52. EDWARDS LIFESCIENCES: NET SALES, 20152017 (USD MILLION)

FIGURE 53. EDWARDS LIFESCIENCES: REVENUE SHARE BY PRODUCT, 2017 (%)

FIGURE 54. EDWARDS LIFESCIENCES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 55. TELEFLEX: NET SALES, 20152017 (USD MILLION)

FIGURE 56. TELEFLEX: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 57. STRYKER: NET SALES, 20152017 (USD MILLION)

FIGURE 58. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 59. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)


List Of Table

LIST OF TABLES

 

TABLE 01. GLOBAL CATHETERS MARKET, BY PRODUCT, 20172025

TABLE 02. GLOBAL CATHETERS MARKET, FOR CARDIOVASCULAR CATHETERS, BY REGION, 20172025 (USD MILLION)

TABLE 03. GLOBAL CATHETERS MARKET, FOR CARDIOVASCULAR CATHETERS, BY TYPE, 20172025 (USD MILLION)

TABLE 04. GLOBAL CATHETERS MARKET, FOR ELECTROPHYSIOLOGY CATHETERS, 20172025 (USD MILLION)

TABLE 05. GLOBAL CATHETERS MARKET, FOR PTCA BALLOONS CATHETERS, 20172025 (USD MILLION)

TABLE 06. GLOBAL CATHETERS MARKET, FOR IVUS CATHETERS, 20172025 (USD MILLION)

TABLE 07. GLOBAL CATHETERS MARKET, FOR PTA BALLOONS CATHETERS, 20172025 (USD MILLION)

TABLE 08. GLOBAL CATHETERS MARKET, FOR OTHER CATHETERS, 20172025 (USD MILLION)

TABLE 09. GLOBAL NEUROVASCULAR CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 10. GLOBAL CATHETERS MARKET, FOR UROLOGICAL CATHETERS BY REGION, 20172025 (USD MILLION)

TABLE 11. GLOBAL CATHETERS MARKET, FOR UROLOGICAL CATHETERS BY TYPE, 20172025 (USD MILLION)

TABLE 12. GLOBAL CATHETERS MARKET, FOR DIALYSIS CATHETER, BY REGION, 20172025 (USD MILLION)

TABLE 13. GLOBAL DIALYSIS CATHETER MARKET, BY TYPE, 20172025 (USD MILLION)

TABLE 14. GLOBAL HEMODIALYSIS CATHETER MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 15. GLOBAL PERITONEAL CATHETER MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 16. GLOBAL URINARY CATHETER MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 17. GLOBAL INTRAVENOUS CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 18. GLOBAL CENTRAL VENOUS CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 19. GLOBAL PERIPHERAL VENOUS CATHETERS MARKET, BY REGION, 20172025

TABLE 20. GLOBAL SPECIALTY CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 21. GLOBAL WOUND / SURGICAL DRAIN MARKET, BY REGION, 20172025

TABLE 22. GLOBAL OXIMETRY MARKET, BY REGION, 20172025

TABLE 23. GLOBAL THERMODILUTION MARKET, BY REGION, 20172025

TABLE 24. GLOBAL IUI CATHETERS MARKET, BY REGION, 20172025

TABLE 25. GLOBAL CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 26. NORTH AMERICA CATHETERS MARKET, BY PRODUCT, 20172025 (USD MILLION)

TABLE 27. NORTH AMERICA CATHETERS MARKET, BY COUNTRY, 20172025 (USD MILLION)

TABLE 28. EUROPE CATHETERS MARKET, BY PRODUCT, 20172025 (USD MILLION)

TABLE 29. EUROPE CATHETERS MARKET, BY COUNTRY, 20172025 (USD MILLION)

TABLE 30. ASIA-PACIFIC CATHETERS MARKET, BY COUNTRY, 20172025 (USD MILLION)

TABLE 31. ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT, 20172025 (USD MILLION)

TABLE 32. LAMEA CATHETERS MARKET, BY COUNTRY, 20172025 (USD MILLION)

TABLE 33. LAMEA CATHETERS MARKET, BY PRODUCT, 20172025 (USD MILLION)

TABLE 34. ABBOTT: COMPANY SNAPSHOT

TABLE 35. ABBOTT: OPERATING SEGMENTS

TABLE 36. ABBOTT: PRODUCT PORTFOLIO

TABLE 37. B. BRAUN: COMPANY SNAPSHOT

TABLE 38. B. BRAUN: OPERATING SEGMENTS

TABLE 39. B. BRAUN: PRODUCT PORTFOLIO

TABLE 40. BD: COMPANY SNAPSHOT

TABLE 41. BD: OPERATING SEGMENTS

TABLE 42. B. BRAUN: PRODUCT PORTFOLIO

TABLE 43. BOSTON SCIENTIFIC: COMPANY SNAPSHOT

TABLE 44. BOSTON SCIENTIFIC: OPERATING SEGMENTS

TABLE 45. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 46. J&J: COMPANY SNAPSHOT

TABLE 47. J&J: OPERATING SEGMENTS

TABLE 48. J&J: PRODUCT PORTFOLIO

TABLE 49. MEDTRONIC: COMPANY SNAPSHOT

TABLE 50. MEDTRONIC: OPERATING SEGMENT

TABLE 51. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 52. EDWARDS LIFESCIENCES: COMPANY SNAPSHOT

TABLE 53. EDWARDS LIFESCIENCES: PRODUCT PORTFOLIO

TABLE 54. TELEFLEX: COMPANY SNAPSHOT

TABLE 55. TELEFLEX: OPERATING SEGMENTS

TABLE 56. TELEFLEX: PRODUCT PORTFOLIO

TABLE 57. COOK MEDICAL: COMPANY SNAPSHOT

TABLE 58. COOK MEDICAL: OPERATING SEGMENTS

TABLE 59. COOK MEDICAL: PRODUCT PORTFOLIO

TABLE 60. STRYKER: COMPANY SNAPSHOT

TABLE 61. STRYKER: OPERATING SEGMENTS

TABLE 62. STRYKER: PRODUCT PORTFOLIO

Licence Rights

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

According to a new report published by Allied Market Research, titled, Catheters Market by Product: Global Opportunity Analysis and Industry Forecast, 2018 to 2025, the global catheters market was valued at USD 10,703 million in 2017 and is projected to reach USD 19,976 million by 2025, growing at a CAGR of 8.0% from 2018 to 2025. North America was the highest revenue contributor in 2017 and is expected to remain the same throughout the forecast period.
 
A catheter is a thin tube made from medical grade materials that serve a comprehensive range of functions. They are medical devices that can easily be inserted in the patient's body for the treatment of various diseases or even perform a surgical procedure. For instance, cardiovascular catheters are used to draw blood and provide treatments, including intravenous fluids, drugs, or blood transfusions. The scope of applications of catheters has widened, as they are used to treat various neurological, cardiovascular, urological, and other disorders, with the help of improved clinical practices and advanced technologies.
 
The catheter devices have gained significant traction in recent years owing to the significant rise in cardiovascular & urological diseases across the globe. A rise in demand for minimally invasive surgeries for the diagnosis and treatment of cardiovascular, neurological, and other diseases drives the growth of the catheters market. Further, catheter-based surgeries are minimally invasive and require shorter recovery times. Surgeries done with the help of catheters are less invasive and lead to faster recovery.
 
Based on the product, the cardiovascular segment accounted for the majority of the catheter market share of the global market in 2017. This is attributed to the significant increase in cardiovascular diseases across the globe and the surge in the use of these catheters for the treatment of the same. However, the urological catheter segment is anticipated to exhibit a prominent growth rate during the forecast period owing to the significant rise in the geriatric population and the use of these catheters to deal with inconsistency.
 
Key Findings of the Catheters market:
 
Based on the product, the cardiovascular catheters segment accounted for nearly half the share of the catheters industry in 2017.
 
The urological catheters segment is anticipated to grow at the highest growth rate throughout the forecast period.
 
Based on the region, North America accounted for a major share of the global catheters market in 2017.
 
LAMEA is anticipated to grow at the highest rate in the catheters market during the analysis period, followed by Asia-Pacific.
 
North America was the leading revenue contributor to the global market in 2017, owing to highly advanced healthcare infrastructure and new product launches by the key players. LAMEA is expected to witness the highest growth rate throughout the forecast period, owing to the increase in awareness among healthcare professionals regarding the use of catheters for the treatment and diagnosis of various diseases including urological, kidney failures, and others.
 
The report provides a comprehensive analysis of the leading companies operating in the global market such as Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, Stryker Corporation, Cook Medical, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic, Inc., Edwards Lifesciences Corp., and Vascular Solutions, Inc. The other players in the value chain (not included in the report) include Other players in the value chain include Hollister Incorporated, Manfred Sauer, Smiths Medical, Wellspect Healthcare, Cure Medical, and Convatech Inc.
READ MORE

Scope

CHAPTER 1: INTRODUCTION

 

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

 

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

 

CHAPTER 2: EXECUTIVE SUMMARY

 

2.1. CXO perspective

 

CHAPTER 3: MARKET OVERVIEW

 

3.1. Market definition and scope

3.2. Key findings

 

3.2.1. Top investment pockets

3.2.2. Top Winning Strategies

 

3.3. Patent Analysis

 

3.3.1. Patent analysis by geography (2016-2018)

3.3.2. Patent analysis by applicants (2015-2016)

 

3.4. Clinical Trials For Catheters

3.5. Porters five forces analysis

3.6. Value chain analysis

 

3.6.1. Primary activities

3.6.2. Support activities

 

3.7. Market share analysis, 2017

3.8. Government regulations and reimbursements

 

3.8.1. Catheter regulation in the U.S. and Europe

3.8.2. Reimbursements

 

3.8.2.1. U.S.

 

3.8.3. Europe

 

3.9. Market dynamics

 

3.9.1. Drivers

 

3.9.1.1. Growing demand for minimally invasive procedures

3.9.1.2. Increase in adoption of catheters

3.9.1.3. Surge in geriatric population

 

3.9.2. Restraints

 

3.9.2.1.Rise in Catheter-associated Urinary Tract Infections (CAUTI)

3.9.2.2.Inadequate quality assurance

 

3.9.3. Opportunities

 

3.9.3.1. Opportunities in emerging economies

 

CHAPTER 4: CATHETERS MARKET, BY PRODUCT

 

4.1. Overview

 

4.1.1. Market size and forecast

 

4.2. Cardiovascular Catheters

 

4.2.1. Key market trends and opportunity

4.2.2. Market size and forecast

4.2.3. Electrophysiology Catheters

 

4.2.3.1. Market size and forecast

 

4.2.4. PTCA Balloons Catheters

 

4.2.4.1. Market size and forecast

 

4.2.5. Intravascular ultrasound (IVUS) Catheters

 

4.2.5.1. Market size and forecast

 

4.2.6. Percutaneous transluminal angioplasty (PTA) balloon Catheters

 

4.2.6.1. Market size and forecast

 

4.2.7. Others

 

4.2.7.1. Market size and forecast

 

4.2.7.1.1. Guiding Catheters

4.2.7.1.2. Angiography catheters

4.2.7.1.3. Pulmonary artery catheters

 

4.3. Neurovascular Catheters

 

4.3.1. Key Market Trends and Opportunity

4.3.2. Market size and forecast

 

4.4. Urological Catheters

 

4.4.1. Key Market Trends and Opportunities

4.4.2. Market size and forecast

4.4.3. Dialysis catheter

 

4.4.3.1. Market size and forecast

4.4.3.2. Hemodialysis catheter

 

4.4.3.2.1. Market size and forecast

 

4.4.3.3. Peritoneal catheter

 

4.4.3.3.1. Market size and forecast

 

4.4.4. Urinary catheter

 

4.4.4.1. Market size and forecast

4.4.4.2. Foley Catheters

 

4.4.4.2.1. Market size and forecast

 

4.4.4.3. Intermittent Catheters

 

4.4.4.3.1. Market size and forecast

 

4.4.4.4. External Catheters

 

4.4.4.4.1. Market size and forecast

 

4.5. Intravenous Catheters

 

4.5.1. Key market trends and opportunities

4.5.2. Market size and forecast

4.5.3. Central venous catheters

 

4.5.3.1. Market size and forecast

 

4.5.4. Peripheral venous catheters

 

4.5.4.1. Market size and forecast

4.5.4.2. Integrated Catheters

 

4.5.4.2.1. Market size and forecast

 

4.5.4.3. Short Catheter

 

4.5.4.3.1. Market size and forecast

 

4.6. Specialty Catheters

 

4.6.1. Key market trends and opportunity

4.6.2. Market size and forecast

4.6.3. Wound / Surgical drain

 

4.6.3.1. Market size and forecast

 

4.6.4. Oximetry

 

4.6.4.1. Market size and forecast

 

4.6.5. Thermodilution

 

4.6.5.1. Market size and forecast

 

4.6.6. IUI catheters

 

4.6.6.1. Market size and forecast

 

CHAPTER 5: CATHETERS MARKET, BY REGION

 

5.1. Overview

 

5.1.1. Market size and forecast

 

5.2. North America

 

5.2.1. Key trends and opportunities

5.2.2. North America market size & forecast, by product

5.2.3. North America market size & forecast, by country

 

5.2.3.1. U.S. market size & forecast

5.2.3.2. Canada market size & forecast

5.2.3.3. Mexico market size & forecast

 

5.3. Europe

 

5.3.1. Key trends and opportunities

5.3.2. Europe market size & forecast, by product

5.3.3. Europe market size & forecast for catheters market, by country

 

5.3.3.1. Germany market size & forecast

5.3.3.2. France market size & forecast

5.3.3.3. UK market size & forecast

5.3.3.4. Italy market size & forecast

5.3.3.5. Russia market size & forecast

5.3.3.6. Rest of Europe market size & forecast

 

5.4. Asia-Pacific

 

5.4.1. Key trends and opportunities

5.4.2. Asia-Pacific market size & forecast, by country

5.4.3. Asia-Pacific market size & forecast, by product

 

5.4.3.1. Australia market size & forecast

5.4.3.2. China market size & forecast

5.4.3.3. India market size & forecast

5.4.3.4. Japan market size & forecast

5.4.3.5. Rest of Asia-Pacific market size & forecast

 

5.5. LAMEA

 

5.5.1. Key trends and opportunities

5.5.2. LAMEA market size & forecast, by country

5.5.3. LAMEA market size & forecast, by product

 

5.5.3.1. Brazil market size & forecast

5.5.3.2. Saudi Arabia market size & forecast

5.5.3.3. Turkey market size & forecast

5.5.3.4. Rest of LAMEA market size & forecast

 

CHAPTER 6: COMPANY PROFILES

 

6.1. Abbott Laboratories

 

6.1.1. Company overview

6.1.2. Company snapshot

6.1.3. Operating business segments

6.1.4. Product portfolio

6.1.5. Business performance

6.1.6. Key strategic moves and developments

 

6.2. B. Braun Melsungen AG

 

6.2.1. Company overview

6.2.2. Company snapshot

6.2.3. Operating business segments

6.2.4. Product portfolio

6.2.5. Business performance

 

6.3. Becton, Dickinson and Company

 

6.3.1. Company overview

6.3.2. Company snapshot

6.3.3. Operating business segments

6.3.4. Product portfolio

6.3.5. Business performance

6.3.6. Key strategic moves and developments

 

6.4. Boston Scientific Corporation

 

6.4.1. Company overview

6.4.2. Company snapshot

6.4.3. Operating business segments

6.4.4. Product portfolio

6.4.5. Business performance

6.4.1. Key strategic moves and developments

 

6.5. Johnson & Johnson

 

6.5.1. Company overview

6.5.2. Company snapshot

6.5.3. Operating business segments

6.5.4. Product portfolio

6.5.5. Business performance

6.5.6. Key strategic moves and developments

 

6.6. Medtronic Plc.

 

6.6.1. Company overview

6.6.2. Company snapshot

6.6.3. Operating business segment

6.6.4. Product portfolio

6.6.5. Business performance

6.6.6. Key strategic moves and developments

 

6.7. Edwards Lifesciences Corporation

 

6.7.1. Company overview

6.7.2. Company snapshot

6.7.3. Operating business segments

6.7.4. Product portfolio

6.7.5. Business performance

 

6.8. Teleflex Incorporated

 

6.8.1. Company overview

6.8.2. Company snapshot

6.8.3. Operating business segments

6.8.4. Product portfolio

6.8.5. Business performance

 

6.9. Cook Medical Inc.

 

6.9.1. Company overview

6.9.2. Company snapshot

6.9.3. Operating business segments

6.9.4. Product portfolio

 

6.10. Stryker Corporation

 

6.10.1. Company overview

6.10.2. Company snapshot

6.10.3. Operating business segments

6.10.4. Product portfolio

6.10.5. Business performance

6.10.6. Key strategic moves and developments


List Of Figure

LIST OF FIGURES

 

FIGURE 01. CATHETERS MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*

FIGURE 06. PATENT ANALYSIS BY GEOGRAPHY (2015-2016)

FIGURE 07. PATENT ANALYSIS BY APPLICANT (2015-2016)

FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 09. LOW BARGAINING POWER OF BUYERS

FIGURE 10. LOW THREAT OF SUBSTITUTION

FIGURE 11. LOW THREAT OF NEW ENTRANTS

FIGURE 12. MODERTAE COMPETITIVE RIVALRY

FIGURE 13. VALUE CHAIN ANALYSIS

FIGURE 14. MARKET SHARE ANALYSIS, 2017

FIGURE 15. GLOBAL CATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES

FIGURE 16. U.S. CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 17. CANADA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 18. MEXICO CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 19. GERMANY CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 20. FRANCE CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 21. UK CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 22. ITALY CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 23. RUSSIA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 24. REST OF EUROPE CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 25. AUSTRALIA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 26. CHINA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 27. INDIA CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 28. JAPAN CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 29. REST OF ASIA-PACIFIC CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 30. BRAZIL CATHETERS MARKET, 2017-2025 (USD MILLION)

FIGURE 31. SAUDI ARABIA CATHETERS MARKET, 20172025 (USD MILLION)

FIGURE 32. TURKEY CATHETERS MARKET, 20172025 (USD MILLION)

FIGURE 33. REST OF LAMEA CATHETERS MARKET, 20172025 (USD MILLION)

FIGURE 34. ABBOTT: NET SALES, 20152017 (USD MILLION)

FIGURE 35. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 36. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 37. B. BRAUN: NET SALES, 20152017(USD MILLION)

FIGURE 38. B. BRAUN: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 39. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2017(%)

FIGURE 40. BD: NET SALES, 20152017 (USD MILLION)

FIGURE 41. BD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 42. BD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 43. BOSTON SCIENTIFIC: NET SALES, 20152017 (USD MILLION)

FIGURE 44. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 45. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 46. J&J: NET SALES, 20152017 (USD MILLION)

FIGURE 47. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 48. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 49. MEDTRONIC: NET SALES, 20152017(USD MILLION)

FIGURE 50. MEDTRONIC: REVENUE SHARE PER SEGMENT 2017(%)

FIGURE 51. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY 2017(%)

FIGURE 52. EDWARDS LIFESCIENCES: NET SALES, 20152017 (USD MILLION)

FIGURE 53. EDWARDS LIFESCIENCES: REVENUE SHARE BY PRODUCT, 2017 (%)

FIGURE 54. EDWARDS LIFESCIENCES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 55. TELEFLEX: NET SALES, 20152017 (USD MILLION)

FIGURE 56. TELEFLEX: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 57. STRYKER: NET SALES, 20152017 (USD MILLION)

FIGURE 58. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 59. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)


List Of Table

LIST OF TABLES

 

TABLE 01. GLOBAL CATHETERS MARKET, BY PRODUCT, 20172025

TABLE 02. GLOBAL CATHETERS MARKET, FOR CARDIOVASCULAR CATHETERS, BY REGION, 20172025 (USD MILLION)

TABLE 03. GLOBAL CATHETERS MARKET, FOR CARDIOVASCULAR CATHETERS, BY TYPE, 20172025 (USD MILLION)

TABLE 04. GLOBAL CATHETERS MARKET, FOR ELECTROPHYSIOLOGY CATHETERS, 20172025 (USD MILLION)

TABLE 05. GLOBAL CATHETERS MARKET, FOR PTCA BALLOONS CATHETERS, 20172025 (USD MILLION)

TABLE 06. GLOBAL CATHETERS MARKET, FOR IVUS CATHETERS, 20172025 (USD MILLION)

TABLE 07. GLOBAL CATHETERS MARKET, FOR PTA BALLOONS CATHETERS, 20172025 (USD MILLION)

TABLE 08. GLOBAL CATHETERS MARKET, FOR OTHER CATHETERS, 20172025 (USD MILLION)

TABLE 09. GLOBAL NEUROVASCULAR CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 10. GLOBAL CATHETERS MARKET, FOR UROLOGICAL CATHETERS BY REGION, 20172025 (USD MILLION)

TABLE 11. GLOBAL CATHETERS MARKET, FOR UROLOGICAL CATHETERS BY TYPE, 20172025 (USD MILLION)

TABLE 12. GLOBAL CATHETERS MARKET, FOR DIALYSIS CATHETER, BY REGION, 20172025 (USD MILLION)

TABLE 13. GLOBAL DIALYSIS CATHETER MARKET, BY TYPE, 20172025 (USD MILLION)

TABLE 14. GLOBAL HEMODIALYSIS CATHETER MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 15. GLOBAL PERITONEAL CATHETER MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 16. GLOBAL URINARY CATHETER MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 17. GLOBAL INTRAVENOUS CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 18. GLOBAL CENTRAL VENOUS CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 19. GLOBAL PERIPHERAL VENOUS CATHETERS MARKET, BY REGION, 20172025

TABLE 20. GLOBAL SPECIALTY CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 21. GLOBAL WOUND / SURGICAL DRAIN MARKET, BY REGION, 20172025

TABLE 22. GLOBAL OXIMETRY MARKET, BY REGION, 20172025

TABLE 23. GLOBAL THERMODILUTION MARKET, BY REGION, 20172025

TABLE 24. GLOBAL IUI CATHETERS MARKET, BY REGION, 20172025

TABLE 25. GLOBAL CATHETERS MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 26. NORTH AMERICA CATHETERS MARKET, BY PRODUCT, 20172025 (USD MILLION)

TABLE 27. NORTH AMERICA CATHETERS MARKET, BY COUNTRY, 20172025 (USD MILLION)

TABLE 28. EUROPE CATHETERS MARKET, BY PRODUCT, 20172025 (USD MILLION)

TABLE 29. EUROPE CATHETERS MARKET, BY COUNTRY, 20172025 (USD MILLION)

TABLE 30. ASIA-PACIFIC CATHETERS MARKET, BY COUNTRY, 20172025 (USD MILLION)

TABLE 31. ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT, 20172025 (USD MILLION)

TABLE 32. LAMEA CATHETERS MARKET, BY COUNTRY, 20172025 (USD MILLION)

TABLE 33. LAMEA CATHETERS MARKET, BY PRODUCT, 20172025 (USD MILLION)

TABLE 34. ABBOTT: COMPANY SNAPSHOT

TABLE 35. ABBOTT: OPERATING SEGMENTS

TABLE 36. ABBOTT: PRODUCT PORTFOLIO

TABLE 37. B. BRAUN: COMPANY SNAPSHOT

TABLE 38. B. BRAUN: OPERATING SEGMENTS

TABLE 39. B. BRAUN: PRODUCT PORTFOLIO

TABLE 40. BD: COMPANY SNAPSHOT

TABLE 41. BD: OPERATING SEGMENTS

TABLE 42. B. BRAUN: PRODUCT PORTFOLIO

TABLE 43. BOSTON SCIENTIFIC: COMPANY SNAPSHOT

TABLE 44. BOSTON SCIENTIFIC: OPERATING SEGMENTS

TABLE 45. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 46. J&J: COMPANY SNAPSHOT

TABLE 47. J&J: OPERATING SEGMENTS

TABLE 48. J&J: PRODUCT PORTFOLIO

TABLE 49. MEDTRONIC: COMPANY SNAPSHOT

TABLE 50. MEDTRONIC: OPERATING SEGMENT

TABLE 51. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 52. EDWARDS LIFESCIENCES: COMPANY SNAPSHOT

TABLE 53. EDWARDS LIFESCIENCES: PRODUCT PORTFOLIO

TABLE 54. TELEFLEX: COMPANY SNAPSHOT

TABLE 55. TELEFLEX: OPERATING SEGMENTS

TABLE 56. TELEFLEX: PRODUCT PORTFOLIO

TABLE 57. COOK MEDICAL: COMPANY SNAPSHOT

TABLE 58. COOK MEDICAL: OPERATING SEGMENTS

TABLE 59. COOK MEDICAL: PRODUCT PORTFOLIO

TABLE 60. STRYKER: COMPANY SNAPSHOT

TABLE 61. STRYKER: OPERATING SEGMENTS

TABLE 62. STRYKER: PRODUCT PORTFOLIO

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS